Literature DB >> 7472689

Ability of primary care physicians to diagnose and manage Pneumocystis carinii pneumonia.

J R Curtis1, D S Paauw, M D Wenrich, J D Carline, P G Ramsey.   

Abstract

This study assesses the ability of primary care physicians to diagnose and manage Pneumocystis carinii pneumonia (PCP) in a standardized patient (SP) with unidentified HIV infection. One hundred thirty-four primary care physicians from five Northwest states saw an SP with unidentified HIV infection who presented with symptoms, chest radiograph, and arterial blood gas results classic for PCP. Seventy-seven percent of the physicians included PCP in their differential diagnoses and 71% identified the SP's HIV risk. However, only a minority of the physicians indicated that they would initiate an appropriate diagnostic evaluation or appropriate therapy: 47% ordered a diagnostic test for PCP, 31% initiated an antibiotic appropriate for PCP, and 12% initiated an adequate dose of trimethoprim - sulfamethoxazole. Only 6% of the physicians initiated adjunctive prednisone therapy, even though prednisone was indicated because of the blood gas result. These findings suggest significant delay in diagnosis and treatment had these physicians been treating an actual patient with PCP.

Entities:  

Mesh:

Year:  1995        PMID: 7472689     DOI: 10.1007/bf02599841

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  16 in total

1.  The AIDS-related experiences and practices of primary care physicians in Los Angeles: 1984-89.

Authors:  C E Lewis; K Montgomery
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

2.  Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome.

Authors: 
Journal:  N Engl J Med       Date:  1990-11-22       Impact factor: 91.245

3.  Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.

Authors:  I Medina; J Mills; G Leoung; P C Hopewell; B Lee; G Modin; N Benowitz; C B Wofsy
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

4.  Internal medicine residents' skills at identification of HIV-risk behavior and HIV-related disease.

Authors:  J R Curtis; D S Paauw; M D Wenrich; J D Carline; P G Ramsey
Journal:  Acad Med       Date:  1994-10       Impact factor: 6.893

5.  The effect of educational preparation on physician performance with a sexually transmitted disease-simulated patient.

Authors:  M A Bowman; N K Russell; B O Boekeloo; I Z Rafi; D L Rabin
Journal:  Arch Intern Med       Date:  1992-09

6.  A survey of physicians' knowledge and application of AIDS prevention capabilities.

Authors:  K L McCance; R Moser; K R Smith
Journal:  Am J Prev Med       Date:  1991 May-Jun       Impact factor: 5.043

7.  Relation between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: experience from 3,126 cases in New York City in 1987.

Authors:  C L Bennett; J Adams; P Gertler; R E Park; S Gilman; L George; M Shapiro; R H Brook
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

8.  Spectrum of disease in persons with human immunodeficiency virus infection in the United States.

Authors:  K M Farizo; J W Buehler; M E Chamberland; B M Whyte; E S Froelicher; S G Hopkins; C M Reed; E D Mokotoff; D L Cohn; S Troxler
Journal:  JAMA       Date:  1992-04-01       Impact factor: 56.272

9.  The relation between hospital experience and mortality for patients with AIDS.

Authors:  V E Stone; G R Seage; T Hertz; A M Epstein
Journal:  JAMA       Date:  1992-11-18       Impact factor: 56.272

10.  The periodic health examination provided to asymptomatic older women: an assessment using standardized patients.

Authors:  P A Carney; A J Dietrich; D H Freeman; L A Mott
Journal:  Ann Intern Med       Date:  1993-07-15       Impact factor: 25.391

View more
  8 in total

1.  Quality in HIV/AIDS care. Specialty-related or experience-related?

Authors:  W C Holmes
Journal:  J Gen Intern Med       Date:  1997-03       Impact factor: 5.128

2.  Clinic HIV-focused features and prevention of Pneumocystis carinii pneumonia.

Authors:  B J Turner; L Markson; J Cocroft; L Cosler; W W Hauck
Journal:  J Gen Intern Med       Date:  1998-01       Impact factor: 5.128

Review 3.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

4.  HIV risk screening in the primary care setting. Assessment of physicians skills.

Authors:  M D Wenrich; J R Curtis; J D Carline; D S Paauw; P G Ramsey
Journal:  J Gen Intern Med       Date:  1997-02       Impact factor: 5.128

5.  Relation of physician specialty and HIV/AIDS experience to choice of guideline-recommended antiretroviral therapy.

Authors:  V E Stone; F F Mansourati; R M Poses; K H Mayer
Journal:  J Gen Intern Med       Date:  2001-06       Impact factor: 5.128

6.  Specialty training and specialization among physicians who treat HIV/AIDS in the United States.

Authors:  Bruce E Landon; Ira B Wilson; Neil S Wenger; Susan E Cohn; Carl J Fichtenbaum; Samuel A Bozzette; Martin F Shapiro; Paul D Cleary
Journal:  J Gen Intern Med       Date:  2002-01       Impact factor: 5.128

Review 7.  Pneumocystis jirovecii pneumonia in developing countries.

Authors:  Y de Armas Rodríguez; G Wissmann; A L Müller; M A Pederiva; M C Brum; R L Brackmann; V Capó de Paz; E J Calderón
Journal:  Parasite       Date:  2011-08       Impact factor: 3.000

8.  Does service integration improve technical quality of care in low-resource settings? An evaluation of a model integrating HIV care into family planning services in Kenya.

Authors:  Richard Mutemwa; Susannah H Mayhew; Charlotte E Warren; Timothy Abuya; Charity Ndwiga; Jackline Kivunaga
Journal:  Health Policy Plan       Date:  2017-11-01       Impact factor: 3.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.